| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
| 1. | Diabetes Mellitus
04/01/2006
- "The structure of CPT-2 in complex with the generic CPT inhibitor ST1326 ([R]-N-[tetradecylcarbamoyl]-aminocarnitine), a substrate analog mimicking palmitoylcarnitine and currently in clinical trials for diabetes mellitus treatment, was solved at 2.5 A resolution"
Get all the results and reference details, order at left... |
| 1 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
| 1. | ST1326
|
| 2. | Palmitoylcarnitine
|
| 2 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
| Price: | $490.00 access via web interface, 1 year subscription |
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |